Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community
Kotsiou, O.S.; Papagiannis, D.; Fradelos, E.C.; Siachpazidou, D.I.; Perlepe, G.; Miziou, A.; Kyritsis, A.; Vavougios, G.D.; Kalantzis, G.; Gourgoulianis, K.I. Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community. Int. J. Environ. Res. Public Health 2022, 19, 407. https://doi.org/10.3390/ijerph19010407
Kotsiou OS, Papagiannis D, Fradelos EC, Siachpazidou DI, Perlepe G, Miziou A, Kyritsis A, Vavougios GD, Kalantzis G, Gourgoulianis KI. Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community. International Journal of Environmental Research and Public Health. 2022; 19(1):407. https://doi.org/10.3390/ijerph19010407
Chicago/Turabian StyleKotsiou, Ourania S., Dimitrios Papagiannis, Evangelos C. Fradelos, Dimitra I. Siachpazidou, Garifallia Perlepe, Angeliki Miziou, Athanasios Kyritsis, George D. Vavougios, Georgios Kalantzis, and Konstantinos I. Gourgoulianis. 2022. "Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community" International Journal of Environmental Research and Public Health 19, no. 1: 407. https://doi.org/10.3390/ijerph19010407